Mayne Pharma Receives $14.4M for Legal Costs from Cosette
Key points
- Mayne Pharma received $14.4M from Cosette
- Payment includes legal costs and interest
- Cosette's appeal decision is pending
Full summary
Mayne Pharma Group Limited has received a payment of $14,410,714.49 from Cosette Pharmaceuticals, Inc, as ordered by the Supreme Court of New South Wales. This amount includes Mayne Pharma's legal costs, application costs, and interest. This follows a successful legal battle initiated by Mayne Pharma against Cosette in June 2025, regarding Cosette's termination of the Scheme Implementation Deed. The Court ruled in favor of Mayne Pharma in October 2025, dismissing Cosette's claims and ordering it to pay Mayne Pharma's costs. Cosette appealed the decision in January 2026, and the appeal was heard in June 2026, with a decision yet to be announced.
Summary generated by a large language model. Please interpret with care.